PITTSBURGH – A federal judge has granted a final opportunity to amend a class action complaint, for plaintiffs who claimed significant harm was sustained on behalf of themselves and/or their loved ones, based on a shortage of a pharmaceutical drug named Fabrazyme that began in 2009 and lasted until 2012.
/PRNewswire/ Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected.
Chiesi Global Rare Diseases Announces Multiple Presentations at SSIEM Annual Symposium 2023 streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Chiesi Global Rare Diseases Announces Multiple Presentations at SSIEM Annual Symposium 2023 kptv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kptv.com Daily Mail and Mail on Sunday newspapers.